NEWER, MORE EFFECTIVE DIABETES DRUGS REACH ONLY A FRACTION OF PATIENTS
A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new guidelines.
Type 2 diabetes (T2D), a condition in which the body can't use insulin to clear sugar from the bloodstream, affects 1 in 10 Americans. It comes with grave health risks, including cardiovascular and kidney disease.
The study assessed medications that patients received within a year of T2D diagnosis. During the period under review - 2014 to 2022 - groups like the American Diabetes Association and the American Heart Association began encouraging the use of newer medications over some older, less effective ones.
2025-07-01T05:33:18Z